Sign in | About Us | Contact Us

Product CAS# Supplier

Sign in | Join free | Shopping Online | Product Index | Buy,Sell (New)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

0

1

2

3

4

5

6

7

8

9

Zentiva board accepts Sanofi¡¯s revised €1.8bn offer        Novartis/Schering AG To Introduce Vatalanib For The Second-line Treatment Of Patients With Metastatic Colorectal Cancer        Brazil, Gilead agree AIDS drug price cut        FDA blocks imports from two Ranbaxy plants        Acquisition looming in Calyx Pharma's future, says CEO        Brazil Rejects Patent On An Essential AIDS Medicine        "Shelved" Antihistamine Shows Promise in Alzheimer's Disease        ¡¸ÍËÒ۵ġ¹¿¹×éÖ¯°· Dimebon ¿´Ëƶ԰¢×Ⱥ£Ä¬ÊÏÖ¢ÓÐЧ        δGleevec(imatinib mesylate) Receives FDA Priority Review As First Therapy To Reduce Recurrence Of Gastrointestinal Stromal Tumors After Surgery        Brazil rejects Gilead patent for HIV/AIDS drug Viread (Tenofovir DF)        International Organizations and Foreign Government Agencies for Food Drug Administratation        Thai Government Deals Patent Blow to Big Pharma¡¯s Cancer Drug Monopoly        Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics        Roche vs Cipla: Will the Real Price of "Tarceva" Please Show Up?        FDA MedWatch - July 2008 Drug Safety-Related Labeling Changes for 35 Drugs Now Available on Web        Sutent? Provides Superior Quality of Life Compared with Interferon in Kidney Cancer        All About Lung Cancer        DSM and MorphoSys add MOR202 to Ab deal        Siemens building radiopharma sites in India        Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)        Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older        Cancer drugs postcode lottery        Ramelteon: A Novel Approach in the Treatment of Insomnia        ¶à°Ðµã¿¹Ö×ÁöÀÒ°±ËἤøÒÖÖƼÁ        Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla? (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries        Sprycel (Dasatinib) Effective for CNS Philadelphia Chromosome-positive Leukemia        Phase I-II Trial of Bortezomib Plus Oral Cyclophosphamide and Prednisone in Relapsed and Refractory Multiple Myeloma        Cipla eyeing copies of 20 patented drugs        Cyclacel Publishes Study of Seliciclib Synergy with Tarceva(Erlotinib) and Herceptin in Journal Clinical Cancer Research        FDA MedWatch- Avastin (bevacizumab) and Sunitinib Malate- Reports of Microangiopathic Hemolytic Anemia In Patients Treated With This Combination

ËÕICP±¸05037505ºÅ

Copyright 2007 © ChemLink & ChemicalInfo & Pharm-ChemNet . All rights reserved.